Osaic Holdings
RCKT icon

Osaic Holdings’s Rocket Pharmaceuticals RCKT Stock Holding History

Osaic Holdings’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41K Sell
1,582
-10
-0.6% -$33 ﹤0.01% 6894
2026
Q1 		$5.7K Sell
1,592
-19
-1% -$76 ﹤0.01% 6621
2025
Q4 		$5.66K Sell
1,611
-1,437
-47% -$4.92K ﹤0.01% 6642
2025
Q3 		$9.98K Sell
3,048
-365
-11% -$1.15K ﹤0.01% 6358
2025
Q2 		$9.35K Sell
3,413
-221
-6% -$1.12K ﹤0.01% 6193
2025
Q1 		$24.2K Buy
3,634
+2,874
+378% +$28.4K ﹤0.01% 5221
2024
Q4 		$9.55K Buy
760
+379
+99% +$5.71K ﹤0.01% 5834
2024
Q3 		$7.04K Sell
381
-14
-4% -$287 ﹤0.01% 6032
2024
Q2 		$8.51K Buy
395
+139
+54% +$3.19K ﹤0.01% 5886
2024
Q1 		$6.9K Sell
256
-2,276
-90% -$64.7K ﹤0.01% 5948
2023
Q4 		$75.8K Sell
2,532
-221
-8% -$4.88K ﹤0.01% 4613
2023
Q3 		$56.4K Buy
2,753
+504
+22% +$9.16K ﹤0.01% 4914
2023
Q2 		$44.7K Buy
2,249
+250
+13% +$5.05K ﹤0.01% 5011
2023
Q1 		$34.2K Buy
1,999
+76
+4% +$1.49K ﹤0.01% 5217
2022
Q4 		$37.8K Buy
1,923
+1,723
+862% +$31.7K ﹤0.01% 5142
2022
Q3 		$3K Sell
200
-45
-18% -$702 ﹤0.01% 6659
2022
Q2 		$4K Sell
245
-42
-15% -$501 ﹤0.01% 6620
2022
Q1 		$4K Sell
287
-22
-7% -$380 ﹤0.01% 6629
2021
Q4 		$6K Buy
309
+33
+12% +$900 ﹤0.01% 6555
2021
Q3 		$8K Hold
276
– – ﹤0.01% 6337
2021
Q2 		$12K Sell
276
-98
-26% -$4.26K ﹤0.01% 5963
2021
Q1 		$16K Buy
374
+143
+62% +$7.85K ﹤0.01% 5624
2020
Q4 		$13K Buy
231
+200
+645% +$7.29K ﹤0.01% 5406
2020
Q3 		$1K Hold
31
– – ﹤0.01% 6057
2020
Q2 		$1K Hold
31
– – ﹤0.01% 5973
2020
Q1 		$0 Buy
+31
New +$614 ﹤0.01% 6156

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Osaic Holdings's RCKT Position: Q2 2026 in Review

Osaic Holdings reduced its Rocket Pharmaceuticals (RCKT) stake by 0.63% in Q2 2026, selling an estimated $33 and leaving 1,582 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #6894.

Osaic Holdings first reported a position in RCKT in Q1 2020 and has held it in 26 quarters since. The position peaked at $75.8K in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Osaic Holdings held 1,582 shares of Rocket Pharmaceuticals worth $5.41K as of Q2 2026.
  • Osaic Holdings sold 10 Rocket Pharmaceuticals shares in Q2 2026, an estimated $33.
  • Rocket Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6894 holding.
  • Osaic Holdings first reported a position in Rocket Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Rocket Pharmaceuticals position peaked at $75.8K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.